Profound Medical (TSE:PRN) has released an update.
Profound Medical Corp., specializing in incision-free therapies for diseased tissue, will be attending the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference in New York City. The conference, scheduled for September 12, 2024, will not be webcast as it consists exclusively of one-on-one investor meetings. Profound Medical is known for its TULSA-PRO system, which is a non-invasive prostate treatment that preserves urinary and sexual function, and its Sonalleve platform, used for treating uterine fibroids and bone metastases pain.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
